Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its 2025 fiscal year ended September 30, 2025. The Company is hosting a conference call today, November 25, 2025, ...
Data from the KT-621 BROADEN2 Phase 2b AD patient trial expected to be reported by mid-2027KT-621 BREADTH Phase 2b trial in asthma on track to ...
I will now hand the conference call over to Vince Anzalone, Vice President of Investor Relations for Arrowhead. Please go ahead, Vince. Thank you, Andrew. Good afternoon, and thank you for joining us ...
20h
ICSE Class 10 Maths Exam Pattern 2025-26: Paper Pattern, Marking Scheme, and Topic-wise Weightage
Check the structured 80-mark theory paper and chapter-wise weightage. Master Algebra (32 marks) and Commercial Mathematics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback